Endonovo Therapeutics (ENDV) Short Interest Ratio & Short Volume → Does this make you sick? (From Allegiance Gold) (Ad) Free ENDV Stock Alerts $0.0015 0.00 (-40.00%) (As of 05/10/2024 08:56 PM ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Endonovo Therapeutics Short Interest DataCurrent Short Volume8,300 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$26.56Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares349,390,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume10,951,000 sharesAverage Trading Volume1,144,684 sharesToday's Volume Vs. Average957% Short Selling Endonovo Therapeutics ? Sign up to receive the latest short interest report for Endonovo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENDV Short Interest Over TimeENDV Days to Cover Over TimeENDV Percentage of Float Shorted Over Time Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action Endonovo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,300 shares $26.56 No ChangeN/A0 $0.00 3/15/202410,000 shares $35.00 No ChangeN/A0.1 $0.00 2/15/202427,000 shares $118.80 +130.8%N/A0 $0.00 1/15/202421,300 shares $208.74 +309.6%N/A0 $0.01 12/31/20235,200 shares $45.24 -73.2%N/A0 $0.01 12/15/202319,400 shares $176.54 +9,600.0%N/A0 $0.01 Get the Latest News and Ratings for ENDV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2023200 shares $2.30 No ChangeN/A0 $0.01 10/31/20233,700 shares $51.43 No ChangeN/A0 $0.01 9/15/20231,500 shares $16.67 No ChangeN/A0 $0.01 8/31/20231,500 shares $19.05 -60.5%N/A0 $0.01 8/15/20233,800 shares $41.80 -39.7%N/A0 $0.01 7/31/20236,300 shares $69.30 No ChangeN/A0.1 $0.01 6/30/2023300 shares $4.35 No ChangeN/A0 $0.01 4/30/202341,700 shares $417.00 -3.0%N/A0.1 $0.01 4/15/202343,000 shares $712.51 +15.0%N/A0.1 $0.02 3/31/202337,400 shares $617.10 No ChangeN/A0.1 $0.02 2/15/202322,300 shares $367.95 +2,377.8%N/A0 $0.02 1/31/2023900 shares $16.92 +50.0%N/A0 $0.02 1/15/2023600 shares $9.30 No ChangeN/A0 $0.02 12/15/2022300 shares $3.93 -78.6%N/A0 $0.01 11/30/20221,400 shares $9.94 -6.7%N/A0 $0.01 11/15/20221,500 shares $13.20 No ChangeN/A0 $0.01 10/31/20221,500 shares $12.00 -76.9%N/A0 $0.01 10/15/20226,500 shares $52.00 -13.3%N/A0 $0.01 9/30/20227,500 shares $55.50 No ChangeN/A0 $0.01 8/31/202229,000 shares $216.05 +28,900.0%N/A0.1 $0.01 8/15/2022100 shares $0.83 No ChangeN/A0 $0.01 7/15/20229,000 shares $90.00 -4.3%N/A0.1 $0.01 6/30/20229,400 shares $84.60 No ChangeN/A0 $0.01 2/28/202210,900 shares $196.20 +118.0%N/A0 $0.02 2/15/20225,000 shares $85.00 No ChangeN/A0 $0.02 9/15/2021800 shares $19.20 No ChangeN/A0 $0.02 8/13/2021600 shares $16.32 -98.7%N/A0 $0.03 7/30/202147,000 shares $1,179.70 +526.7%N/A0.1 $0.03 7/15/20217,500 shares $269.25 No ChangeN/A0 $0.04 6/15/20212,900 shares $87.29 +93.3%N/A0 $0.03 5/28/20211,500 shares $50.10 -79.7%N/A0 $0.03 5/14/20217,400 shares $295.26 No ChangeN/A0 $0.04 4/15/202136,200 shares $1,086.00 No ChangeN/A0 $0.03 3/15/202115,300 shares $676.26 No ChangeN/A0 $0.04Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit ENDV Short Interest - Frequently Asked Questions What is Endonovo Therapeutics' current short interest? Short interest is the volume of Endonovo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 8,300 shares of ENDV short. Learn More on Endonovo Therapeutics' current short interest. Is Endonovo Therapeutics' short interest increasing or decreasing? Endonovo Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 8,300 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Endonovo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Endonovo Therapeutics: Tivic Health Systems, Inc. (3.74%), Helius Medical Technologies, Inc. (7.57%), Micron Solutions, Inc. (0.07%), Nuwellis, Inc. (15.44%), Akanda Corp. (3.46%), Scinai Immunotherapeutics Ltd. (0.47%), GlobeStar Therapeutics Co. (0.00%), Acorda Therapeutics, Inc. (0.66%), RespireRx Pharmaceuticals Inc. (0.01%), TC Biopharm (Holdings) Plc (5.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Endonovo Therapeutics stock? Short selling ENDV is an investing strategy that aims to generate trading profit from Endonovo Therapeutics as its price is falling. ENDV shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Endonovo Therapeutics? A short squeeze for Endonovo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENDV, which in turn drives the price of the stock up even further. How often is Endonovo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENDV, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TIVC Short Interest HSDT Short Interest MICR Short Interest NUWE Short Interest AKAN Short Interest SCNI Short Interest GSTC Short Interest ACOR Short Interest RSPI Short Interest TCBP Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENDV) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorObama’s Forever Term [exposed]Porter & CompanyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press